Redox regulation – Natural compound as regulators of inflammation signaling
Traditional West African pharmacopeia, plants and derived compounds for cancer therapy
Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1
Resveratrol initiates differentiation of mouse skeletal muscle-derived C2C12 myoblasts
Berberine: New perspectives for old remedies
Key cell signaling pathways modulated by zerumbone: Role in the prevention and treatment of cancer
Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management
Molecular insight in the multifunctional activities of Withaferin A
Redox modulation of the DNA damage response
Reactive oxygen species (ROS) and sensitization to TRAIL-induced apoptosis, in Bayesian network modelling of HeLa cell response to LY303511
PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells ☆
Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence
Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders
Development of chemical inhibitors of the SARS coronavirus: Viral helicase as a potential target
Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease
Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors